Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China · Delayed Price · Currency is CNY 11.18
-0.09 (-0.80%)
Sep 11, 2026, 3:04 PM CST
SHE:300003 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
| 20,609 | 29,144 | 20,904 | 30,095 | 42,506 | 40,557 | |
Market Cap Growth | -38.77% | 39.42% | -30.54% | -29.20% | 4.81% | -16.74% |
Enterprise Value | 24,020 | 32,743 | 24,462 | 31,247 | 43,010 | 42,910 |
Last Close Price | 11.18 | 15.60 | 10.97 | 15.06 | 21.09 | 20.47 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 26.74 | 30.30 | 84.65 | 23.92 | 19.29 | 23.59 |
Forward PE | 24.37 | 25.97 | 20.25 | 13.76 | 22.09 | 14.60 |
PS Ratio | 3.26 | 4.50 | 3.43 | 3.77 | 4.01 | 3.81 |
PB Ratio | 1.15 | 1.64 | 1.25 | 1.72 | 2.60 | 3.30 |
P/TBV Ratio | 1.94 | 2.80 | 2.19 | 2.83 | 4.07 | 5.96 |
P/FCF Ratio | 34.71 | 33.35 | 275.70 | 206.57 | 22.54 | 19.52 |
P/OCF Ratio | 13.62 | 19.21 | 28.46 | 30.39 | 15.23 | 13.25 |
PEG Ratio | - | 0.63 | 0.63 | 0.63 | 0.63 | 0.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.80 | 5.05 | 4.01 | 3.92 | 4.05 | 4.03 |
EV/EBITDA Ratio | 14.90 | 17.79 | 26.39 | 15.31 | 13.42 | 14.28 |
EV/EBIT Ratio | 24.85 | 26.01 | 57.16 | 19.61 | 15.39 | 16.43 |
EV/FCF Ratio | 40.45 | 37.47 | 322.62 | 214.48 | 22.81 | 20.65 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.36 | 0.36 | 0.35 | 0.28 | 0.27 | 0.39 |
Debt / EBITDA Ratio | 3.94 | 3.37 | 5.84 | 2.33 | 1.32 | 1.58 |
Debt / FCF Ratio | 10.70 | 7.31 | 76.10 | 33.71 | 2.30 | 2.33 |
Net Debt / Equity Ratio | 0.11 | 0.10 | 0.11 | 0.02 | -0.09 | 0.09 |
Net Debt / EBITDA Ratio | 1.25 | 0.95 | 1.92 | 0.20 | -0.44 | 0.35 |
Net Debt / FCF Ratio | 3.28 | 2.01 | 23.44 | 2.85 | -0.74 | 0.50 |
Asset Turnover | 0.25 | 0.26 | 0.25 | 0.32 | 0.47 | 0.55 |
Inventory Turnover | 1.26 | 1.21 | 1.18 | 1.31 | 1.91 | 2.48 |
Quick Ratio | 1.69 | 1.41 | 1.64 | 1.74 | 1.51 | 1.74 |
Current Ratio | 2.29 | 2.01 | 2.34 | 2.48 | 2.02 | 2.44 |
Return on Equity (ROE) | 4.40% | 5.91% | 1.15% | 7.63% | 15.68% | 15.61% |
Return on Assets (ROA) | 2.34% | 3.10% | 1.08% | 4.02% | 7.73% | 8.40% |
Return on Invested Capital (ROIC) | 4.36% | 5.55% | 2.05% | 8.06% | 16.99% | 16.21% |
Return on Capital Employed (ROCE) | 4.40% | 5.90% | 2.00% | 7.50% | 14.60% | 15.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Earnings Yield | 3.74% | 3.30% | 1.18% | 4.18% | 5.18% | 4.24% |
FCF Yield | 2.88% | 3.00% | 0.36% | 0.48% | 4.44% | 5.12% |
Dividend Yield | 2.75% | 2.09% | 2.53% | 2.20% | 1.62% | 1.34% |
Payout Ratio | 109.23% | 70.85% | 401.27% | 61.09% | 28.84% | 34.14% |
Buyback Yield / Dilution | 0.07% | 0.27% | 0.74% | -2.48% | -0.50% | -1.75% |
Total Shareholder Return | 2.82% | 2.36% | 3.26% | -0.28% | 1.12% | -0.40% |